Elsevier

Experimental Neurology

Volume 149, Issue 1, January 1998, Pages 97-108
Experimental Neurology

Regular Article
Safety of Intrastriatal Neurotransplantation for Huntington's Disease Patients

https://doi.org/10.1006/exnr.1997.6685Get rights and content

Abstract

Fetal neural transplantation has been shown to be a feasible, safe, and according to a number of recent reports, effective treatment for Parkinson's disease (PD). Fetal striatal transplantation may be as feasible, safe, and effective a treatment for Huntington's disease (HD), a disorder for which there is currently no effective treatment. This report describes our experience with fetal striatal transplantation to adult striatum in three HD patients. Three moderately advanced, nondemented HD patients received transplantation of fetal striatal tissue. The striatal precursor was selectively obtained from the lateral ganglionic eminence. Each patient received bilateral grafts from five to eight donors, placed into the caudate nucleus (one graft on each side) and the putamen (four grafts on each side). All three patients had HD as documented by family history, DNA heterozygosity (17–20 and 48–51 repeats), magnetic resonance imaging (MRI) revealing striatal atrophy, and 2-deoxyglucose positron emission tomography revealing striatal hypometabolism. All patients had been evaluated using the Unified Huntington's Disease Rating Scale and appropriate neuropsychological tests for at least 3 months prior to transplantation. One year following transplantation, MRI of all three patients revealed that the grafts survived and grew within the striatum without displacing the surrounding tissue. No patients demonstrated adverse effects of the surgery or the associated cyclosporin immunosuppression, nor did any patient exhibit deterioration following the procedure. The limited experience provided by these three patients indicates that fetal tissue transplantation can be performed in HD patients without unexpected complications.

References (52)

  • R.E. Oberg et al.

    Levels of motor planning: Cognition and the control of movement

    Trends. Neurosci.

    (1981)
  • C.W. Olanow et al.

    Fetal nigral transplantation as a therapy for Parkinson's disease

    Trends. Neurosci.

    (1996)
  • M. Peschanski et al.

    Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease

    Neuroscience

    (1995)
  • L.M. Philpott et al.

    Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations

    Cell Transplant.

    (1997)
  • L.L. Pundt et al.

    Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits

    Neurosci. Res.

    (1996)
  • L.L. Pundt et al.

    Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation

    Brain Res. Bull.

    (1996)
  • L.L. Pundt et al.

    Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease

    Neurosci. Res.

    (1997)
  • P.R. Sanberg et al.

    Behavioral effects of fetal neural transplants: Relevance to Huntington's disease

    Brain Res. Bull.

    (1993)
  • K.M. Shannon et al.

    Neural transplantation for Huntington's disease: Experimental rationale and recommendations for clinical trials

    Cell Transplant.

    (1996)
  • N.E. Simmons et al.

    Magnetic resonance imaging of neuronal grafts in the primate

    Exp. Neurol.

    (1994)
  • K. Wictorin et al.

    Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum. I. Subcortical afferents

    Neuroscience

    (1988)
  • A. Bjorklund et al.

    Functional capacity of striatal transplants in the rat Huntington model

    Functional Neural Transplantation

    (1994)
  • S.E. Browne et al.

    Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases

    Biochem. Soc. Trans.

    (1994)
  • S.E. Browne et al.

    Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

    Ann. Neurol.

    (1997)
  • F. Carella et al.

    Adult onset myoclonic Huntington's disease

    Mov. Disord.

    (1993)
  • Cited by (162)

    • Rehabilitation training in neural restitution

      2017, Progress in Brain Research
    • Use of human stem cells in Huntington disease modeling and translational research

      2016, Experimental Neurology
      Citation Excerpt :

      In addition, abortions may be restricted or prohibited according to the legislation of some countries. Initial studies on the safety of this procedure reported encouraging results, including patient tolerance of the transplantation procedure and the administration of immunosuppressant drugs to avoid rejection of the transplant (Kopyov et al., 1998). Remarkably, three of the five tested HD patients showed a beneficial effect of a bilateral neurograft on motor and cognitive functions one year after the last transplantation (Bachoud-Levi et al., 2000b).

    View all citing articles on Scopus

    A. BjorklundS. B. Dunnett

    View full text